EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type ( KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR)

Sunakawa, Yu ; Ichikawa, Wataru ; Tsuji, Akihito ; Moran, Miriana ; Astrow, Stephanie H. ; Yang, Dongyun ; Zhang, Wu ; Takahashi, Takehiro ; Denda, Tadamichi ; Shimada, Ken ; Kochi, Mitsugu ; Nakamura, Masato ; Kotaka, Masahito ; Segawa, Yoshihiko ; Takeuchi, Masahiro ; Lenz, Heinz-Josef ; Fujii, Masashi ; Nakajima, Toshifusa

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.618-618 [Periódico revisado por pares]

Texto completo disponível